Cargando…

Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece

BACKGROUND: An economic evaluation was undertaken in order to assess several therapeutic alternatives (rosuvastatin, atorvastatin, simvastatin, and pravastatin) for the prevention of primary and secondary cardiovascular events in high-risk patients in Greece. METHODS: A probabilistic Markov model wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fragoulakis, Vassilis, Kourlaba, Georgia, Maniadakis, Nikolaos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377435/ https://www.ncbi.nlm.nih.gov/pubmed/22719213 http://dx.doi.org/10.2147/CEOR.S31376

Ejemplares similares

Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece
por: Fragoulakis, Vassilis, et al.
Publicado: (2012)

Economic evaluation of alternative assisted reproduction techniques in management of infertility in Greece
por: Fragoulakis, Vassilis, et al.
Publicado: (2012)

Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece; A telephone survey
por: Maniadakis, Nikos, et al.
Publicado: (2011)

Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2014)

Estimating the long-term effects of in vitro fertilization in Greece: an analysis based on a lifetime-investment model
por: Fragoulakis, Vassilis, et al.
Publicado: (2013)

Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece
por: Fragoulakis, Vasilis, et al.
Publicado: (2015)

Economic evaluation of trimetazidine in the management of chronic stable angina in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2016)

Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece
por: Fragoulakis, Vassilis, et al.
Publicado: (2015)

Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece
por: Maniadakis, Nikos, et al.
Publicado: (2013)

Economic evaluation of therapies for patients suffering from relapsed-refractory multiple myeloma in Greece
por: Fragoulakis, V, et al.
Publicado: (2013)

Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2014)

Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study
por: Kourlaba, Georgia, et al.
Publicado: (2015)

The disease burden of chronic obstructive pulmonary disease in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2016)

Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components
por: Stafylas, Panagiotis, et al.
Publicado: (2015)

A systematic review of the effectiveness of taxes on nonalcoholic beverages and high-in-fat foods as a means to prevent obesity trends
por: Maniadakis, Nikolaos, et al.
Publicado: (2013)

Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study
por: Kourlaba, Georgia, et al.
Publicado: (2015)

Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece
por: Tzanetakos, Charalampos, et al.
Publicado: (2014)

The efficiency of the public dental services (PDS) in Cyprus and selected determinants
por: Charalambous, Chrystalla, et al.
Publicado: (2013)

Economic analysis of coronary artery bypass grafting with minimal versus conventional extracorporeal circulation
por: Anastasiadis, K, et al.
Publicado: (2013)

Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey
por: Theodorou, Mamas, et al.
Publicado: (2009)

Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema
por: Kourlaba, Georgia, et al.
Publicado: (2016)

Statins for primary cardiovascular prevention in the elderly
por: Pedro-Botet, Juan, et al.
Publicado: (2015)

Treating EGFR-Mutated Oncogene-Addicted Advanced Non–Small-Cell Lung Cancer in the Era of Economic Crisis in Greece: Challenges and Opportunities
por: Fountzilas, Elena, et al.
Publicado: (2018)

When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
por: Catalá-López, Ferrán, et al.
Publicado: (2013)

Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece
por: Gourzoulidis, George, et al.
Publicado: (2022)

Physicians' Perceptions and Adherence to Guidelines for the Management of Hypertension: A National, Multicentre, Prospective Study
por: Theodorou, Mamas, et al.
Publicado: (2012)

Use of Aspirin and Statin as primary prevention for cardiovascular diseases
por: Alkhail, Bahaa Aba, et al.
Publicado: (2016)

Statins alone or polypill for primary prevention of cardiovascular diseases
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2016)

Burden of Atopic Dermatitis in Adults in Greece: Results from a Nationwide Survey
por: Gregoriou, Stamatis, et al.
Publicado: (2022)

Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury
por: Coste, Joël, et al.
Publicado: (2019)

Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin
por: Mitchell, Dominic, et al.
Publicado: (2016)

The economics of primary prevention of cardiovascular disease – a systematic review of economic evaluations
por: Schwappach, David LB, et al.
Publicado: (2007)

Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status
por: Maniadakis, N., et al.
Publicado: (2017)

Statin for the Primary Prevention of Cardiovascular Disease in Patients with Diabetes Mellitus
por: Koo, Bo Kyung
Publicado: (2014)

Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
por: Byrne, Paula, et al.
Publicado: (2019)

Underutilization of Statin Therapy for Secondary Prevention of Cardiovascular Disease Among Older Adults
por: Musich, Shirley, et al.
Publicado: (2019)

Evaluating an implementation strategy in cardiovascular prevention to improve prescribing of statins in Germany: an intention to treat analysis
por: Keller, Heidemarie, et al.
Publicado: (2013)

A window-DEA based efficiency evaluation of the public hospital sector in Greece during the 5-year economic crisis
por: Flokou, Angeliki, et al.
Publicado: (2017)

Hoping rosuvastatin for primary prevention of cardiovascular events, are all statins similar and are we ready for statinizing the globe?
por: Kumar, Arun H. S.
Publicado: (2016)

Primary prevention with statins in cardiovascular diseases: A Saudi Arabian perspective
por: Mahmood, D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sbdcai8en42gsddg8p1nn11mes